KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 162 filers reported holding KRYSTAL BIOTECH INC in Q1 2023. The put-call ratio across all filers is 1.80 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,924 | -1.2% | 189 | 0.0% | 0.00% | – |
| Q2 2023 | $22,189 | +54.8% | 189 | +5.6% | 0.00% | – |
| Q1 2023 | $14,331 | -5.8% | 179 | -6.8% | 0.00% | – |
| Q4 2022 | $15,210 | -10.5% | 192 | -20.0% | 0.00% | – |
| Q3 2022 | $17,000 | -37.0% | 240 | -40.9% | 0.00% | – |
| Q2 2022 | $27,000 | -40.0% | 406 | -39.5% | 0.00% | – |
| Q1 2022 | $45,000 | -22.4% | 671 | -19.6% | 0.00% | – |
| Q4 2021 | $58,000 | +866.7% | 835 | +659.1% | 0.00% | – |
| Q3 2021 | $6,000 | 0.0% | 110 | +17.0% | 0.00% | – |
| Q2 2021 | $6,000 | -62.5% | 94 | -54.1% | 0.00% | – |
| Q1 2021 | $16,000 | +33.3% | 205 | 0.0% | 0.00% | – |
| Q4 2020 | $12,000 | +33.3% | 205 | 0.0% | 0.00% | – |
| Q3 2020 | $9,000 | +12.5% | 205 | 0.0% | 0.00% | – |
| Q2 2020 | $8,000 | – | 205 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 895,000 | $31,079,000 | 9.72% |
| Knoll Capital Management, LLC | 120,212 | $4,174,000 | 3.82% |
| S Squared Technology, LLC | 67,533 | $2,345,000 | 2.07% |
| Redmile Group, LLC | 1,078,300 | $37,444,000 | 1.25% |
| EAM Investors, LLC | 87,914 | $3,053,000 | 0.81% |
| Consonance Capital Management LP | 224,090 | $7,782,000 | 0.77% |
| EAM Global Investors LLC | 41,329 | $1,435,000 | 0.70% |
| SPHERA FUNDS MANAGEMENT LTD. | 117,625 | $4,085,000 | 0.63% |
| GARNET EQUITY CAPITAL HOLDINGS, INC. | 28,000 | $972,000 | 0.62% |
| Atika Capital Management LLC | 58,319 | $2,026,000 | 0.43% |